BROOMFIELD, CO - July 18, 2019 — Flagship Biosciences, the advanced tissue data services company, today announced the addition of Meredith James, HT, PMP, to its executive team as Vice President of Operations. Ms. James brings a wealth of experience gained in over 20...
Broomfield, CO – April 3, 2019 — Flagship Biosciences, the advanced tissue data services company, today announced its membership in Biocom, the association representing the California life science industry. A Flagship representative will also serve on the Biocom...
Westminster, CO – April 1, 2019 — Flagship Biosciences, an advanced tissue data services company, today announced a new distribution channel for its services on Scientist.com, the world’s largest marketplace for outsourced scientific services. “Flagship is excited to...
Hamburg, Germany and Westminster, CO, USA, – March 28, 2019 – Indivumed and Flagship Biosciences, Inc. are pleased to announce a partnership to expand their broad tissue-based biomarker development capabilities, as well as their clinical services to support advanced...
February 19, 2019 – Machine learning, which provides the ability to learn a task from data (without the need of being programmed explicitly), is a key component of any Pathology AI (Artificial Intelligence) system. There are many different approaches in machine...
IntroductionJanuary 14, 2019 – Study of the minuscule is not possible without aid of an instrument because the human retina does not possess sufficient angular resolution to discern microscopic detail at the focal lengths achievable by its natural lens. Thus the...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS
Key takeways: Successful pathology AI does not replace, but assist pathologists in high-complexity tissue analysis Transparency and control is retained in a pathologist-centric AI-based system Pathology AI enables cost effective healthcare by testing for multiple...
The true barrier to artificial intelligence (AI) in pathology is not the technology; it’s the business model. Flagship Biosciences believes that the true opportunity for pathology AI lies in personalized medicine with big data. Better characterization of the patient...
Based on its recent analysis of the global market for artificial intelligence (AI)-based pathology solutions in immuno-oncology (I-O), Frost & Sullivan recognizes Flagship Biosciences, Inc. (Flagship) with the 2018 Global Technology Innovation Award. Each year,...
EVENTS
Utilizing RNAscope in the clinic to handle complex analysis. RNAscope is rapidly becoming a solution for understanding complex biomarker challenges. The benefits and awareness of image analysis in the space of pathology have been widely discussed and rapidly growing....
Technology Leads the Way to Precision Patient Care Digital transformation comes in many flavors. In pathology, it can be as simple as merely scanning pathology slides into whole slide images. However, it can also represent end-to-end digital pathology workflow...
Pathology Visions 2021October 17-19, 2021Digital Pathology: The Future is Here is the theme of this year’s Digital Pathology Association annual conference, Pathology Visions 2021. #PathVisions21 featured a poster from Flagship’s CCO Meredith James on a novel approach...